DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome

Blood Cells, Molecules, and Diseases

Volumn 53, Issue 1-2, 2014, Pages 61-66

  El Ghannam, Doaa ^a   Taalab, Mona M ^a   Ghazy, Hayam F ^a   Eneen, Asmaa F ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Acute myeloid leukemia; DNMT3A; Leukemogenesis; Myelodysplastic syndrome; Oncogenes

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SURVIVAL; CODON; COHORT ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DNMT3A GENE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; AGED; ALLELE; CHROMOSOME ANALYSIS; GENETICS; LEUKEMIA, MYELOID, ACUTE; METABOLISM; MIDDLE AGED; MORTALITY; MUTATION; MUTATION RATE; MYELODYSPLASTIC SYNDROMES; NUCLEOTIDE SEQUENCE; TREATMENT OUTCOME;

DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A;

ADULT; AGED; ALLELES; AMINO ACID SUBSTITUTION; CYTOGENETIC ANALYSIS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MUTATION; MUTATION RATE; MYELODYSPLASTIC SYNDROMES; TREATMENT OUTCOME;

EID: 84900036625     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2014.01.004     Document Type: Article

References (36)

1. Esteller M. Epigenetics in cancer. N. Engl. J. Med. 2008, 358:1148-1159.
2. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 23 2007, 128:683-692.
3. Mizuno S., Chijiwa T., Okamura T., Akashi K., Fukumaki Y., Niho Y., Sasaki H. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 2001, 97:1172-1179.
4. Pezzi A., Moraes L., Valim V., Amorin B., Melchiades G., Oliveira F., da Silva M.A., Matte U., Pombo-de-Oliveira M.S., Bittencourt R., Daudt L., Silla L. DNMT3A mutations in patients with acute myeloid leukemia in South Brazil. Adv. Hematol. 2012, 697691.
5. Brenner C., Fuks F. DNA methyltransferases: facts, clues, mysteries. Curr. Top. Microbiol. Immunol. 2006, 301:45-66.
6. Chen T., Li E. Establishment and maintenance of DNA methylation patterns in mammals. Curr. Top. Microbiol. Immunol. 2006, 301:179-201.
7. Thol F., Damm F., Lüdeking A., Winschel C., Wagner K., Morgan M., Yun H., Göhring G., Schlegelberger B., Hoelzer D., Lübbert M., Kanz L., Fiedler W., Kirchner H., Heil G., Krauter J., Ganser A., Heuser M. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J. Clin. Oncol. 2011, 20(29):2889-2896.
8. Ley T.J., Ding L., Walter M.J., McLellan M.D., Lamprecht T., Larson D.E., Kandoth C., Payton J.E., Baty J., Welch J., Harris C.C., Lichti C.F., Townsend R.R., Fulton R.S., Dooling D.J., Koboldt D.C., Schmidt H., Zhang Q., Osborne J.R., Lin L., O'Laughlin M., McMichael J.F., Delehaunty K.D., McGrath S.D., Fulton L.A., Magrini V.J., Vickery T.L., Hundal J., Cook L.L., Conyers J.J., Swift G.W., Reed J.P., Alldredge P.A., Wylie T., Walker J., Kalicki J., Watson M.A., Heath S., Shannon W.D., Varghese N., Nagarajan R., Westervelt P., Tomasson M.H., Link D.C., Graubert T.A., DiPersio J.F., Mardis E.R., Wilson R.K. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 2010, 363:2424-2433.
9. Shah M.Y., Licht J.D. DNMT3A mutations in acute myeloid leukemia. Nat. Genet. 2011, 43:289-290.
10. Stegelmann F., Bullinger L., Schlenk R.F., Paschka P., Griesshammer M., Blersch C., Kuhn S., Schauer S., Döhner H., Döhner K. DNMT3A mutations in myeloproliferative neoplasms. Leukemia 2011, 25:1217-1219.
11. Walter M.J., Ding L., Shen D., Shao J., Grillot M., McLellan M., Fulton R., Schmidt H., Kalicki-Veizer J., O'Laughlin M., Kandoth C., Baty J., Westervelt P., DiPersio J.F., Mardis E.R., Wilson R.K., Ley T.J., Graubert T.A. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011, 25:1153-1158.
12. Cowell J.K., Hawthorn L. The application of microarray technology to the analysis of the cancer genome. Curr Mol Med. 2007, 7:103-120.
13. Yan X.J., Xu J., Gu Z.H., Pan C.M., Lu G., Shen Y., Shi J.Y., Zhu Y.M., Tang L., Zhang X.W., Liang W.X., Mi J.Q., Song H.D., Li K.Q., Chen Z., Chen S.J. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat. Genet. 2011, 43:309-315.
14. Ribeiro A.F., Pratcorona M., Erpelinck-Verschueren C., Rockova V., Sanders M., Abbas S., Figueroa M.E., Zeilemaker A., Melnick A., Löwenberg B., Valk P.J., Delwel R. Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia. Blood 2012, 119:5824-5831.
15. Patel J.P., Gönen M., Figueroa M.E., Fernandez H., Sun Z., Racevskis J., Van Vlierberghe P., Dolgalev I., Thomas S., Aminova O., Huberman K., Cheng J., Viale A., Socci N.D., Heguy A., Cherry A., Vance G., Higgins R.R., Ketterling R.P., Gallagher R.E., Litzow M., van den Brink M.R., Lazarus H.M., Rowe J.M., Luger S., Ferrando A., Paietta E., Tallman M.S., Melnick A., Abdel-Wahab O., Levine R.L. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N. Engl. J. Med. 2012, 366:1079-1089.
16. Lin J., Yao D.M., Qian J., Chen Q., Qian W., Li Y., Yang J., Wang C.Z., Chai H.Y., Qian Z., Xiao G.F., Xu W.R. Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. PLoS One 2011, 6:e26906.
17. Greer J., Baer M., Kinnery M. Acute myelogenous leukemia. Wintrobe's Clinical Hematology 2009, 2045-2062. Lippincott Williams and Wilkins, Philadelphia. 12th ed. G. Lee, J. Foester, J. Leukens, F. Pareskerva, J. Greer, G. Rogers (Eds.).
18. Silverman L.R., Holland J.F., Weinberg R.S., Alter B.P., Davis R.B., Ellison R.R., Demakos E.P., Cornell C.J., Carey R.W., Schiffer C. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes. Leukemia 1993, 7(Suppl. 1):21-29.
19. Guidelines for cancer cytogenetics. Supplement to An International System for Human Cytogenetic Nomenclature 1995, Karger, Basel, Switzerland. F. Mittelmann (Ed.).
20. Röllig C., Bornhäuser M., Thiede C., Taube F., Kramer M., Mohr B., Aulitzky W., Bodenstein H., Tischler H.J., Stuhlmann R., Schuler U., Stölzel F., von Bonin M., Wandt H., Schäfer-Eckart K., Schaich M., Ehninger G. Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European Leukemia Net recommendations: evaluation of the proposed reporting system. J. Clin. Oncol. 2011, 29:2758-2765.
21. Hou H.A., Kuo Y.Y., Liu C.Y., Chou W.C., Lee M.C., Chen C.Y., Lin L.I., Tseng M.H., Huang C.F., Chiang Y.C., Lee F.Y., Liu M.C., Liu C.W., Tang J.L., Yao M., Huang S.Y., Ko B.S., Hsu S.C., Wu S.J., Tsay W., Chen Y.C., Tien H.F. DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications. Blood 2012, 119:559-568.
22. Yamashita Y., Yuan J., Suetake I., Suzuki H., Ishikawa Y., Choi Y.L., Ueno T., Soda M., Hamada T., Haruta H., Takada S., Miyazaki Y., Kiyoi H., Ito E., Naoe T., Tomonaga M., Toyota M., Tajima S., Iwama A., Mano H. Array-based genomic resequencing of human leukemia. Oncogene 2010, 29:3723-3731.
23. Gowher H., Loutchanwoot P., Vorobjeva O., Handa V., Jurkowska R.Z., Jurkowski T.P., Jeltsch A. Mutational analysis of the catalytic domain of the murine Dnmt3a DNA-(cytosine C5)-methyltransferase. J. Mol. Biol. 2006, 357:928-941.
24. Turek-Plewa J., Jagodziński P.P. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell. Mol. Biol. Lett. 2005, 10:631-647.
25. Jia D., Jurkowska R.Z., Zhang X., Jeltsch A., Cheng X. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature 2007, 449(7159):248-251.
26. Deng T., Kuang Y., Wang L., Li J., Wang Z., Fei J. An essential role for DNA methyltransferase 3a in melanoma tumorigenesis. Biochem. Biophys. Res. Commun. 2009, 387:611-616.
27. Hervouet E., Vallette F.M., Cartron P.F. Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation. Epigenetics 2009, 4:487-499.
28. Wang Y.A., Kamarova Y., Shen K.C., Jiang Z., Hahn M.J., Wang Y., Brooks S.C. DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression. Cancer Biol. Ther. 2005, 4:1138-1143.
29. Brenner C., Deplus R., Didelot C., Loriot A., Viré E., De Smet C., Gutierrez A., Danovi D., Bernard D., Boon T., Pelicci P.G., Amati B., Kouzarides T., de Launoit Y., Di Croce L., Fuks F. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 2005, 24:336-346.
30. Jones P.A., Liang G. Rethinking how DNA methylation patterns are maintained. Nat. Rev. Genet. 2009, 10:805-811.
31. Marková J., Michková P., Burčková K., Březinová J., Michalová K., Dohnalová A., Maaloufová J.S., Soukup P., Vítek A., Cetkovský P., Schwarz J. Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia. Eur. J. Haematol. 2012, 88:128-135.
32. Thol F., Winschel C., Lüdeking A., Yun H., Friesen I., Damm F., Wagner K., Krauter J., Heuser M., Ganser A. Rare occurrence of DNMT3A mutations in myelodysplastic syndromes. Haematologica 2011, 96:1870-1873.
33. Marcucci G., Metzeler K.H., Schwind S., Becker H., Maharry K., Mrózek K., Radmacher M.D., Kohlschmidt J., Nicolet D., Whitman S.P., Wu Y.Z., Powell B.L., Carter T.H., Kolitz J.E., Wetzler M., Carroll A.J., Baer M.R., Moore J.O., Caligiuri M.A., Larson R.A., Bloomfield C.D. Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. J. Clin. Oncol. 2012, 30:742-750.
34. Schlenk R.F., Döhner K., Krauter J., Fröhling S., Corbacioglu A., Bullinger L., Habdank M., Späth D., Morgan M., Benner A., Schlegelberger B., Heil G., Ganser A., Döhner H. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 2008, 358:1909-1918.
35. Falini B., Mecucci C., Tiacci E., Alcalay M., Rosati R., Pasqualucci L., La Starza R., Diverio D., Colombo E., Santucci A., Bigerna B., Pacini R., Pucciarini A., Liso A., Vignetti M., Fazi P., Meani N., Pettirossi V., Saglio G., Mandelli F., Lo-Coco F., Pelicci P.G., Martelli M.F. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N. Engl. J. Med. 2005, 352:254-266.
36. Schlenk R.F., Döhner K., Kneba M., Götze K., Hartmann F., Del Valle F., Kirchen H., Koller E., Fischer J.T., Bullinger L., Habdank M., Späth D., Groner S., Krebs B., Kayser S., Corbacioglu A., Anhalt A., Benner A., Fröhling S., Döhner H. Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Haematologica 2009, 94:54-60.